Women & Infants Hospital
Providence, Rhode Island, 02905, United States
NCT Number: NCT00840983
The purpose of this study was to see if a brief delay in cord clamping for 30 to 45 seconds would result in higher hematocrit levels, fewer transfusions, healthier lungs, and better motor function at 40 wks and 7 months of age.
Looking for future studies?
Notify MeFemale
Interventional
Phase 1
Providence, Rhode Island, 02905, United States
When cord clamping is delayed at birth or the cord is milked, infants receive a placental transfusion of 10-15 mL/kg during the first few minutes of life. This additional blood improves hemodynamic stability and may reduce the risk of intraventricular hemorrhage (IVH) and the vulnerability of infants to inflammatory processes. This blood also contains stem cells that are important in repairing tissue and building immunocompetence.
The current randomized controlled trial prospectively tested the effects of DCC for 30-45 seconds followed by 1 cord milking with the aim of confirming our prior work and providing long-term follow-up. Our a priori hypotheses were that DCC would reduce the incidence of IVH, LOS, and result in better motor function at 18-22 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
cord clamping was delayed for 30 to 45 seconds and infant was held lower than the level of the placenta
Other names: cord clamping time
Time frame: 36 wks postmenstrual age
Time frame: Hospital discharge
Time frame: 7 months corrected age
Time frame: NICU stay
Time frame: NICU Stay
University of Rhode Island
Other
Effects of Delayed Cord Clamping in Very Low Birth Weight (VLBW) Infants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05311228
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Jakarta, DKI Jakarta, Indonesia
View Trial DetailsNCT04077333
Brain Diseases, Bronchopulmonary Dysplasia
Beijing, China
View Trial DetailsNCT02784821
Bacteremia, Bacterial Infections
Gainesville, Florida, United States
View Trial DetailsNCT03717584
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Sacramento, California, United States
View Trial Details